Congress trades in CVS Corp (CVS)
10 of the members we track disclosed 12 purchases of CVS between 2021-10-20 and 2026-03-27, and 32 sales. Here is what the stock did afterwards.
Every purchase is measured over the three months after the transaction date, against XLV — the ETF standing in for Healthcare & Pharma — over exactly the same dates. The second figure is the one that carries information: the first mostly reflects what the sector did. How CVS was classified.
How these buys are tagged
6 of these purchases were made by a member whose own committee oversees Healthcare & Pharma.
| Buys | Number | Return after 3 months | vs. sector | Beat their sector |
|---|---|---|---|---|
| All buys | 12 | +6.0% | +5.9% | 67% |
| Notable (committee-flagged) | 6 | +14.8% | +13.3% | 83% |
| Unaligned (no committee overlap) | 6 | -2.9% | -1.4% | 50% |
| Cluster, excl. mega-caps | 0 | Too few buys to measure | ||
| Not clustered, excl. mega-caps | 12 | +6.0% | +5.9% | 67% |
Who bought the most
- Dan Goldman — 2 buys
- Donald Beyer — 2 buys
- Alan Armstrong — 1 buy
- John Boozman — 1 buy
- Lisa C. McClain — 1 buy
Every disclosed purchase
| Member | Bought disclosed |
Signal | Price | 1W | 1M | 3M | vs sector |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 2026-07-21 |
Notable | $70.08 | +4.9% | +11.2% | +48.9% | +37.0% |
| John Boozman | 2026-01-29 2026-02-15 |
Notable | $74.44 | +2.5% | +7.3% | +11.9% | +17.0% |
| Lisa C. McClain | 2025-10-30 2025-11-21 |
Unaligned | $76.69 | +2.6% | +4.8% | -2.9% | -9.5% |
| Robert Bresnahan | 2025-02-25 2025-03-27 |
Unaligned | $63.66 | +0.9% | +6.2% | -3.6% | +7.6% |
| Gilbert Ray Cisneros, Jr. | 2025-01-24 2025-02-11 |
Unaligned | $54.55 | +3.5% | +16.4% | +19.7% | +24.1% |
| Val T. Hoyle | 2024-10-29 2025-09-12 |
Unaligned | $56.25 | -1.6% | +6.6% | +1.9% | +3.2% |
| Dwight Evans | 2023-06-22 2023-07-05 |
Notable | $69.41 | -0.9% | +8.1% | +3.6% | +5.1% |
| Dan Goldman | 2023-03-06 2023-04-17 |
Unaligned | $82.97 | -8.1% | -6.3% | -14.7% | -16.0% |
| Dan Goldman | 2023-01-31 2023-02-24 |
Unaligned | $88.22 | -2.5% | -7.7% | -17.5% | -17.7% |
| Donald Beyer | 2022-01-13 2022-02-01 |
Notable | $105.34 | -2.8% | -1.0% | -1.6% | -4.8% |
| Donald Beyer | 2021-12-21 2022-01-01 |
Notable | $100.79 | +2.0% | +1.6% | +6.4% | +6.9% |
| Thomas Suozzi | 2021-10-20 2021-11-05 |
Notable | $86.55 | +1.8% | +7.6% | +19.5% | +18.7% |
Prices are the closing price on the transaction date, not what was paid: filings never disclose an execution price. Blank figures mean the window has not elapsed yet. Sales are not scored — a sale closes a position rather than opening one — so the 32 disclosed sales of CVS are not in this table.
Download the data behind this page, or read how every figure is calculated. Trades in CVS are a small part of the full rankings, which score each member across everything they bought.
Data last updated .